PLANETS
4.2.2020 03:02:07 CET | Business Wire | Press release
teamLab Planets TOKYO is a museum in Toyosu, Tokyo where you walk through water and can immerse yourself in massive artworks barefoot. In the first year since teamLab Planets TOKYO opened in July of 2018, there have been more than 1.25 million visitors from 106 countries and regions.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200203005275/en/
At teamLab Planets TOKYO, two artworks in the museum will be transformed by cherry blossoms for a limited time from March 1 to April 30, 2020.
Also, with the opening of the Toyosu Fish Market and Edomae Jokamachi nearby, you can enjoy food made using fresh ingredients, collect Japanese Culture souvenirs, and enjoy local shopping.
- Cherry Blossoms Transform Two Artworks
In the work Floating in the Falling Universe of Flowers , flowers bloom and change with every passing minute, creating a universe of life that spreads across the space. For a limited time only, cherry blossoms fall in the art space.
In another artwork, Drawing on the Water Surface Created by the Dance of Koi and People - Infinity , visitors walk barefoot through real water, as koi swim across the infinite water's surface. When the koi collide with people, they bloom into cherry blossoms. The flowers that bloom change in real time according to the seasonal changes of the year.
Check the teamLab Planets website for more details: https://planets.teamlab.art/
teamLab Planets highlight video: https://youtu.be/cqiv_FV8iT4
- Become Bodily Immersed in a Massive Art Space
teamLab Planets is a museum where you walk through water. It consists of 4 vast exhibition spaces with 7 distinct artworks. The artworks are based on art collective teamLab’s concept of “Body Immersive.”
By immersing the entire body with other people in these massive “Body Immersive” artworks, the boundary between the body and the artwork dissolves, the boundaries between the self, others, and the world become something continuous, and we explore a new relationship without boundaries between ourselves and the world.
Visitors enter the museum barefoot, and become completely immersed with other visitors in the vast artwork spaces.
- Artworks Transformed by Cherry Blossoms
Floating in the Falling Universe of Flowers
teamLab, 2016-2018, Interactive Digital Installation, Endless, Sound: Hideaki Takahashi
Artwork: https://planets.teamlab.art/tokyo/ew/fitfuof/
Video: https://youtu.be/FzJ5svgIueQ
A seasonal year of flowers bloom and change with time, life spreads out into the universe.
Lie down or sit still in the space and eventually your body floats and you dissolve into the artwork world.
The artwork is rendered in real time by a computer. I is neither prerecorded nor on loop. Interaction between the viewer and the installation causes continuous change in the artwork.
Flowers grow, bud, bloom, and in time, the petals fall, and the flowers wither and die. The cycle of birth and death continues for perpetuity.
The universe at this moment in time can never be seen again.
Drawing on the Water Surface Created by the Dance of Koi and People - Infinity
teamLab, 2016-2018, Interactive Digital Installation, Endless, Sound: Hideaki Takahashi
Artwork: https://planets.teamlab.art/tokyo/ew/koi_and_people/
Video: https://youtu.be/SsRNptTOniw
Koi swim on the surface of water that stretches out into infinity. People can walk into the water.
The movement of the koi is influenced by the presence of people in the water and also other koi. When the fish collide with people they turn into flowers and scatter. Throughout a year, the flowers that bloom will change along with the seasons.
The trajectory of the koi is determined by the presence of people and these trajectories trace lines on the surface of the water.
The work is rendered in real time by a computer program. It is neither prerecorded nor on loop. The interaction between the viewer and the installation causes continuous change in the artwork. Previous visual states can never be replicated, and will never reoccur.
- Museum overview
teamLab Planets TOKYO
Address: teamLab Planets TOKYO, Toyosu 6-1-16, Koto-ku, Tokyo
Hours: Monday - Thursday 10:00 - 19:00
Friday 10:00 - 21:00
Saturday and the day before holidays 9:00 - 21:00
Sunday and Holidays 9:00 - 19:00
* Last entry 30 minutes before closing.
* Special hours Friday, March 20 - Saturday, April 4: 9:00 - 21:00
* Special hours Sunday, April 5: 9:00 - 19:00
Closed:
Thursday, February 13, 2020
Thursday, March 12, 2020
Monday, April 6, 2020
Tuesday, April 14, 2020
Wednesday, April 15,2020
Admission:
Adults (18 years and older) JPY 3,200
University students / Specialized students JPY 2,500
Junior high school students / High school students JPY 2,000
Children (Ages 4-12) JPY 800
Seniors (65 years and older) JPY 2,400
Disability discount JPY 1,600
teamLab Planets website: https://planets.teamlab.art/
teamLab Planets TOKYO Ticket Store: https://teamlabplanets.dmm.com
* Prices and opening hours are subject to change. Please check the official website before visiting.
- Social Networking Sites:
Instagram: https://www.instagram.com/teamlab.planets/
Facebook: https://www.facebook.com/TL.Planets/
Twitter: https://twitter.com/teamLabPlanets
#teamLabPlanets
- Jointly Managed Food Stand
Everything is in your hand
- Hours -
Monday - Thursday 10:00 - 18:00
Friday 10:00 - 20:00
Saturday and the day before holidays 10:00 - 20:00
Sunday and Holidays 10:00 - 18:00
- Closed -
Same as teamLab Planets
* Establishment may be closed in cases of extreme weather.
Check here for more information: https://planets.teamlab.art/tokyo/foodstand
PLANETS Co., Ltd.
The managing entity for facilities operations at teamLab Planets TOKYO and the associated restaurants.
Address: Tokyo Nihonbashi Tower 26F, 2-7-1 Nihonbashi, Chuo-ku, Tokyo
Representative: Takumi Nomoto
teamLab
teamLab (f. 2001) is an international art collective, an interdisciplinary group of various specialists such as artists, programmers, engineers, CG animators, mathematicians and architects whose collaborative practice seeks to navigate the confluence of art, science, technology, and the natural world.
teamLab aims to explore the relationship between the self and the world and new perceptions through art. In order to understand the world around them, people separate it into independent entities with perceived boundaries between them. teamLab seeks to transcend these boundaries in our perception of the world, of the relationship between the self and the world, and of the continuity of time. Everything exists in a long, fragile yet miraculous, borderless continuity of life.
teamLab has been the subject of numerous exhibitions at venues worldwide, including New York, London, Paris, Singapore, Silicon Valley, Beijing, Taipei, and Melbourne among others. The permanent museums teamLab Borderless opened in Odaiba, Tokyo in June 2018, and teamLab Borderless Shanghai in Huangpu District, Shanghai on November 5, 2019. The massive body immersive space teamLab Planets in Toyosu, Tokyo is on view until Fall 2020. The latest permanent museum teamLab SuperNature in Macao to launch in March, 2020.
teamLab’s works are in the permanent collection of the Art Gallery of New South Wales, Sydney; Art Gallery of South Australia, Adelaide; Asian Art Museum, San Francisco; Asia Society Museum, New York; Borusan Contemporary Art Collection, Istanbul; National Gallery of Victoria, Melbourne; and Amos Rex, Helsinki.
teamLab is represented by Pace Gallery .
teamLab: https://www.teamlab.art/
Instagram: https://instagram.com/teamlab/
facebook: https://www.facebook.com/teamLab.inc
twitter: https://twitter.com/teamLab_net
YouTube: https://www.youtube.com/c/teamLabART
View source version on businesswire.com: https://www.businesswire.com/news/home/20200203005275/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release
Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release
Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom